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Cognitive enhancers are drugs which preferentially affect cholinergic 
transmission in the central nervous system. The cholinergic system in the brain is the 
most seriously damaged neurotransmitter system in Alzheimer,s disease and  
dementia with Lewy bodies. Donepezil is a new cognitive enhancer whose 
mechanism of action consists of reversible specific inhibition  
of acetylcholinesterase activity. Donepezil increases the amount  
of acetylcholine available for neuron-to-neuron communication, which may relieve 
some memory impairment  and thus prolonging of patients' self-support. Present 
thesis classifies cognitive enhancers, it especially describes  
the mechanism of action and effect of donepezil and its therapeutical usage. The 
principal aim of my work was to assess and evaluate the efficacy  
and adverse effects of donepezil from chosen clinical studies in the years  
2003- 2009. The results support the conclusion that donepezil is safe  
and effective for long-term treatment of patients with mild or moderate Alzheimer's 
dementia, vascular dementia, mild cognitive impairment  
and multiple sclerosis. In conclusion of my work I aimed to compare efficacy and the 
occurrence of adverse effects of donepezil with other cognitive enhancers and 
hereafter compare these results with published data concerning particular relative 
drugs. 
 
